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Synthesis of MSX-101 and 102
General information
Unless otherwise noted, all reagents and solvents were purchased from commercial suppliers (Alfa Aesar, Ark Pharm, Combi-Blocks, Samchun Chemicals, Sigma-Aldrich or TCI) and used without further purification.
Reactions were monitored by thin-layer chromatography using Merck TLC Silica gel 60 F254 250 µm plates. Chemical shifts were reported in parts per million (ppm, δ) downfield from tetramethylsilane (TMS, internal standard) with coupling constant J in hertz (Hz). Splitting patterns were described using following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; dd, doublet of doublets; dt, doublet of triplets; td, triplet of doublets; m, multiplet; br, broad signal. High resolution mass spectra (HRMS) analyses were recorded on a DIONEX Ultimate 3000 system (LC) and Thermo Scientific Q-Exactive system (MS) using a Thermo Scientific Hypersil GOLD C18 (2.1 mm × 50 mm, 1.9 µm). 2,3,4,7,8,9,10,11,12,13,14,15,16,17- 
(3S,10R,13R,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-
tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (MSX 101).
To a solution of 25-hydroxycholesterol (20 mg, 0.05 mmol) in pyridine (0.5 ml), acetic anhydride (165 µL, 1.75 mmol) was added and the mixture was stirred at RT for 4 h. The solution was quenched with water, and extracted with DCM. Organic layer is washed with brine and dried with Na2SO4. Concentrated organic mixture is purified over MPLC to provide MSX 101 (12 mg, 54%) as white crystal. 
Biological Methods
Cell culture and drug treatment
Human X-ALD-fibroblasts (GM04904, GM17819; Coriell Institute), human dermal fibroblast (HDF, C-004-5C, Invitrogen) and CCALD-oligodendrocytes were cultured according to the method previously described. 
Determination of VLCFA in cultured X-ALD cells
VLCFAs were determined according to the procedure previously described. 1 Briefly, the cell pellets were resuspended in phosphate-buffered saline (PBS) buffer and then, treated respectively with heptacosanoic acid (C27:0, 20 μg/ml) as the internal standard. The converted methyl esters were extracted with hexane and measured by gas chromatography.
CH25H expression
To knockdown CH25H expression, cells were transfected with scrambled siRNA (4390843, Ambion) or CH25H-targeting siRNAs (5-CCUACAUCACUCCCAGUUU-3) 2 using Lipofectamine TM RNAiMAX (Invitrogen) according to the manufacturer's instructions. For ectopic expression of CH25H, cells were transfected with empty vector or vector with CH25H-EGFP construct using Fugene6 transfection reagent (Roche). Two days after transfection, cells were harvested to measure mRNA levels and VLCFA levels.
Quantitative real-time PCR
Total RNAs were extracted from cells using TRIzol reagent (Invitrogen). The cDNAs were generated with the iScriptTM cDNA synthesis kit (Bio-Rad) from 1 μg of total RNA. Expression of CH25H, ELOVL1, and GAPDH was determined by real-time PCR using SYBRH Premix Ex Taq (Takara). CFX96 Real-Time System (Bio-Rad) was used to carry out all the reactions according to the manufacturer's instructions. Relative expression was expressed as means±SEM obtained from three independent experiments. Real-time PCR was performed using the following specific primer sequences: (human CH25H) forward, ATCACCACATACGTGGGCTTT; reverse, GTCAGGGTGGATCTTGTAGCG and (human ELOVL1)
forward, ACTCAGGGCTGGCCCCACAA; reverse, CGCCCACCCTGACCTTTGGC and (human GAPDH)
foword, CCCCTCAAGGGCATCCTGGGCTA; reverse, GAGGTCCACCACCCTGTTGCTGTA. 
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